According to SPER Market Research, the global infertility treatment market was valued at USD 1.7 Bn in 2021 and estimated to reach USD 2.9 Bn by 2030 with a CAGR of 8.5%.
Declining fertility rates across the globe is a leading driver for the growth of infertility treatment market in the forecast period.
Infertility treatment services are used to assist in reproductive processes and provide ability to conceive child through various technologies such as surgeries, artificial insemination, IVF and surrogacies.
The global fertility rate per women has declined to 2.3 in 2020 from 3.2 in 1990. The global fertility rates will drop even further in 2.0 in 2050.
The infertility treatment techniques help the couples enjoy parenthood affected by infertility in either or both partners. Technological advancements, government initiatives, increasing funding and grants will assist the infertility treatment market to propel in forecast period. However, unsupportive regulatory challenges can limit the growth.
The equipment market is the largest product segment by share in this market. The large share of this segment is mainly ascribed by rapidly evolving technology, expansion of product portfolios and innovative interest of key market players. Asia-Pacific dominated the market by regional segmentation owing to technological advancements, improving healthcare infrastructure, rising healthcare expenditure and penetration of key market players through partnership with domestic players in Asian countries.
The global Infertility Treatment market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Cook Group, DxNow, Inc., Esco Micro Pte. Ltd., FUJIFILM Irvine Scientific, Genea Biomedx, Gynotec B.V., Hamilton Thorne Ltd., IHMedical A/S, InVitroCare Inc., IVFtech ApS, Kitazato Corporation, MedGyn Products, Inc., Nidacon International AB, Rocket Medical plc, SAR Healthline Pvt. Ltd., The Baker Company, Inc., The Cooper Companies Inc., Thermo Fisher Scientific, Inc., Vitrolife, ZEISS Group.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for product segments-Equipment’s (Microscopes, imaging systems, sperm analyzer systems, ovum aspiration pumps, micromanipulator systems, incubators, gas analyzers, laser systems, cryosystems, sperm separation devices), Media & Consumables, Accessories; for Procedure segment- Assisted reproductive Technology, Artificial Insemination, Fertility Surgeries, Other infertility treatment procedures; for Patient type- female infertility treatment, male infertility treatment; for End User-Fertility Centers, Hospitals and Surgical Clinics, Cryobanks, Research Institutes. This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.